Franceschini Fabrizio, Bottau Paolo, Caimmi Silvia, Cardinale Fabio, Crisafulli Giuseppe, Liotti Lucia, Saretta Francesca, Bernardini Roberto, Mori Francesca, Caffarelli Carlo
UOC Pediatria, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", Ancona, Italy.
Acta Biomed. 2019 Jan 28;90(3-S):44-51. doi: 10.23750/abm.v90i3-S.8160.
Adverse drug reactions include drug hypersensitivity reactions (DHRs), which can be immunologically mediated or non-immunologically mediated. The high number of DHRs unconfirmed and/or self-reported is a frequent problem in daily clinical practice, with considerable impact on future prescription choices and patient health. It is important to distinguish between hypersensitivity and non-hypersensitivity reactions by adopting a structured diagnostic approach to confirm or discard the suspected drug, not only to avoid life-threatening reactions, but also to reduce the frequent over-diagnosis of DHRs.
药物不良反应包括药物过敏反应(DHRs),其可由免疫介导或非免疫介导。在日常临床实践中,大量未经证实和/或自我报告的DHRs是一个常见问题,对未来的处方选择和患者健康有相当大的影响。通过采用结构化诊断方法来确认或排除可疑药物,区分过敏反应和非过敏反应很重要,这不仅可以避免危及生命的反应,还可以减少DHRs的频繁过度诊断。